Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Hycor Biomedical General Information
Hycor Biomedical is a leading provider of automated in vitro diagnostic solutions for allergy testing. Its flagship NOVEOS system offers high-sensitivity IgE detection with minimal sample volume requirements and reduced interference compared to legacy technologies. The company holds an estimated 5% global market share in allergy diagnostics. Products are FDA-cleared and CE-marked for clinical use.
Contact Information
Primary Industry
Protein Biomarker Diagnostics
Corporate Office
Garden Grove, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Hycor Biomedical Funding
No funding data available
To view Hycor Biomedical's complete valuation and funding history, request access »